Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8240625 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 9 Pages |
Abstract
GLP-2 has a clear therapeutic potential against both acute and chronic radiation enteritis. This therapeutic effect is mediated through an increased mucosal mass before tissue injury and the stimulation of still unknown mechanisms of tissue response to radiation damage. Although these preliminary results still need to be confirmed, GLP-2 might be a way to limit patient discomfort during radiotherapy and reduce the risk of consequential late effects.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sandra Ph.D., Lars Ph.D., Fabien Ph.D., Marie-Catherine Ph.D., Ulfe Bang Ph.D., Ian Ph.D., Jean M.D., Ph.D., Marc Ph.D., Agnès Ph.D.,